Tag Archives: CEO & Investor Conference

Diabetes: New Mechanisms, New Opportunities

Panelists in the diabetes panel stressed the importance of the growing prevalence of the disease – it’s expected to more than double by 2030. Those are big numbers, particularly because diabetes is the number one cause of preventable blindness. There is a light on the horizon – several new treatments for both Type 1 and Type 2 diabetes: XOMA – two current trials for Type 2 diabetes. XOMA’s drug could be administered once a month Read More >

Health  |  Leave a comment  |  Email This Post
Tags:

Pain “A Pain Free” Guide

The CEO & Investor Conference started out strong with several therapeutic workshops. The Pain “A Pain Free“ Guide to Current Therapies panel shared efforts to develop drugs with greater efficiency and fewer side-effects, including a patch for the site of pain (NeurogesX, Inc.), the use of Morphine products for acute to moderate pain (Javelin Pharmaceuticals, Inc.), and low dosage steroids (CombinatoRX).  Pain is the most common reasons patients seek medical attention and is one of the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags:

10 Years and Counting!

There’s a reason why they call it ‘the largest investor conference focused on the biotech industry.’ The next few days will bring out the major players in biotech, from investors to venture capitalists to companies with innovations worthy of writing home about. And the Daily Update is your cheat sheet for getting late-breaking announcements from companies  and highlights from each day’s sessions. Check out this blog when you’re not at the numerous roundtables & workshops, Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags:

Meet me at CEO

Two days until the CEO & Investor Conference! I’ll be there, will you?

Business and Investments  |  Leave a comment  |  Email This Post
Tags: